date,title,source
Oct-17-18,"Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-18-18,Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results,Business Wire
Oct-18-18,Puma Biotech (PBYI) Rides High on Robust Nerlynx Performance,Zacks
Oct-25-18,Puma Biotech (PBYI) Q3 Earnings Preview: What to Look Out For,Zacks
Nov-01-18,"Puma Biotech (PBYI) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-01-18,Puma Biotech: 3Q Earnings Snapshot,Associated Press
Nov-01-18,"Why Puma Biotechnology, Inc. Stock Is Getting Crushed Today",Motley Fool
Nov-01-18,Puma Biotechnology Reports Third Quarter 2018 Financial Results,Business Wire
Nov-05-18,"Puma Biotech (PBYI) Q3 Loss Narrows, Nerlynx Pulls Stock Down",Zacks
Nov-07-18,Puma Biotechnology to Present at Credit Suisse Healthcare Conference,Business Wire
Nov-07-18,Biotech Stocks and the Midterm Elections,ACCESSWIRE
Nov-09-18,"Investor Expectations to Drive Momentum within Matson, Craft Brew Alliance, Easterly Government Properties, Novanta, Ascena Retail Group, and Puma Biotechnology  Discovering Underlying Factors of Influence",GlobeNewswire
Nov-15-18,Edited Transcript of PBYI earnings conference call or presentation 1-Nov-18 8:30pm GMT,Thomson Reuters StreetEvents
Nov-16-18,Edited Transcript of PBYI earnings conference call or presentation 1-Nov-18 8:30pm GMT,Thomson Reuters StreetEvents
Dec-03-18,Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),Business Wire
Dec-06-18,Here's Why Puma Biotechnology Tanked 37.3% in November,Motley Fool
Dec-06-18,Puma Biotechnology Presents Results of Patient Reported Outcomes in Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2018 San Antonio Breast Cancer Symposium,Business Wire
Dec-06-18,"Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2018 San Antonio Breast Cancer Symposium",Business Wire
Dec-06-18,"Puma Biotechnology Presents Results from the Hormone Receptor Positive Subgroup in Phase III ExteNET Trial of Neratinib for HER2-Amplified, Early Stage Breast Cancer at the 2018 San Antonio Breast Cancer Symposium",Business Wire
Dec-10-18,Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4),Business Wire
Dec-11-18,Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4),Business Wire
Dec-12-18,3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019,Motley Fool
Dec-12-18,"Investor Expectations to Drive Momentum within CatchMark Timber Trust, Edison International, Puma Biotechnology, Maxim Integrated Products, Wabash National, and Resolute Energy  Discovering Underlying Factors of Influence",GlobeNewswire
Dec-14-18,Puma Biotechnology Inc (PBYI): Hedge Fund Sentiment Unchanged,Insider Monkey
Dec-17-18,Puma Bio stock rises more than 9% on drug study,MarketWatch
Dec-17-18,Puma Biotechnology Announces Top Line Results of the Phase III NALA Trial of Neratinib in Patients with HER2-Positive Metastatic Breast Cancer,Business Wire
Dec-18-18,A Bull And Bear Review Positive Results For Puma Biotech's Late-Stage Breast Cancer Drug Trial,Benzinga
Dec-18-18,Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer,Zacks
Dec-18-18,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",Benzinga
Dec-18-18,Today's Research Reports on Trending Tickers: Puma Biotechnology and FibroGen,ACCESSWIRE
Jan-02-19,Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),Business Wire
Jan-03-19,Puma Biotechnology to Present at J. P. Morgan Healthcare Conference,Business Wire
Jan-10-19,Athenex Completes Enrollment Target for Breast Cancer Study,Zacks
Jan-11-19,Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why,Zacks
Jan-17-19,"Detailed Research: Economic Perspectives on Delta Air Lines, Duke Energy, Fiserv, The Chefs' Warehouse, Maxim Integrated Products, and Puma Biotechnology  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Jan-22-19,Is Puma Biotechnology a Buy?,Motley Fool
Feb-04-19,Puma Biotechnology Announces Litigation Victory with Jurys Decision,Business Wire
Feb-06-19,"Need To Know: Puma Biotechnology, Inc. (NASDAQ:PBYI) Insiders Have Been Selling Shares",Simply Wall St.
Feb-13-19,Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results,Business Wire
Feb-14-19,5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings,Zacks
Feb-15-19,Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),Business Wire
Feb-21-19,Puma Biotech (PBYI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Zacks
Feb-26-19,Celcuity Inc. (CELC) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-28-19,Puma Biotechnology Inc (PBYI) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-28-19,Puma Biotechnology Reports Fourth Quarter and Full Year 2018 Financial Results,Business Wire
Feb-28-19,Puma Biotechnology Q4 Earnings Preview,Benzinga
Feb-28-19,Predictive Technology Group Names Jay M. Moyes to Its Board of Directors,GlobeNewswire
Mar-01-19,Puma Biotechnology Earnings: PBYI Stock Skyrockets on Q4 Results,InvestorPlace
Mar-01-19,Cantor Fitzgerald Bumps Puma Biotechnology Price Target On Strong Nerlynx Sales,Benzinga
Mar-01-19,Here's Why Puma Biotechnology Is Soaring Today,Motley Fool
Mar-01-19,"Puma Biotech (PBYI) Q4 Loss Narrows, Nerlynx Pulls Stock Up",Zacks
Mar-01-19,"The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis",Benzinga
Mar-04-19,3 Takeaways from Puma Biotechnology's 2018 Earnings,Motley Fool
Mar-04-19,"Recent Analysis Shows Altria Group, Puma Biotechnology, Tanger Factory Outlet Centers, PTC, Aptiv, and Olin Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Mar-05-19,Puma Biotechnology to Present at Cowens Annual Health Care Conference,Business Wire
Mar-05-19,Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options,Zacks
Mar-08-19,Will Puma Biotechnology Continue to Surge Higher?,Zacks
Mar-14-19,Edited Transcript of PBYI earnings conference call or presentation 28-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-14-19,Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),Business Wire
Mar-14-19,Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why,Zacks
Mar-15-19,Edited Transcript of PBYI earnings conference call or presentation 28-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-18-19,"Why Edwards Lifesciences, Village Farms International, and Puma Biotechnology Jumped Today",Motley Fool
Mar-18-19,"Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for HER2 (ERBB2) Mutant, Metastatic Cervical Cancer at the Society of Gynecologic Oncology (SGO) 2019 Annual Meeting",Business Wire
Mar-19-19,Puma Biotech's (PBYI) Nerlynx Gets Approval in Australia,Zacks
Mar-28-19,Puma Biotechnology Announces Publication of Abstracts on Neratinib for AACR Annual Meeting 2019,Business Wire
Apr-01-19,Here's Why Puma Biotechnology Tumbled on Monday,Motley Fool
Apr-01-19,Options Volume Spikes on Sinking Drug Stock,Schaeffer's Investment Research
Apr-01-19,"The Zacks Analyst Blog Highlights: Celgene, Puma, Exelixis, Enanta and Sage",Zacks
Apr-02-19,"Puma Biotech Out-Licenses Nerlynx Rights in Europe, Stock Down",Zacks
Apr-04-19,Puma Biotechnology Expands Cohorts in Phase II SUMMIT Trial of Neratinib in Cancer Patients with Tumors with Activating EGFR or HER2 Mutations,Business Wire
Apr-05-19,Puma Biotech Adds Two Cohorts to Nerlynx Label Expansion Study,Zacks
Apr-09-19,Here's Why Puma Biotechnology Rose 39.5% in March,Motley Fool
Apr-09-19,Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),Business Wire
Apr-18-19,"Should You Worry About Puma Biotechnology, Inc.'s (NASDAQ:PBYI) CEO Pay?",Simply Wall St.
Apr-25-19,Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results,Business Wire
May-02-19,Analysts Estimate Puma Biotech (PBYI) to Report a Decline in Earnings: What to Look Out for,Zacks
May-03-19,Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),Business Wire
May-08-19,Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference 2019,Business Wire
May-09-19,"Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates",Zacks
May-09-19,Puma Biotech: 1Q Earnings Snapshot,Associated Press
May-09-19,Puma Bio down 33% as more patients forgoing treatment with its cancer drug,MarketWatch
May-09-19,Puma Biotechnology Reports First Quarter 2019 Financial Results,Business Wire
May-09-19,Here's Why Puma Biotechnology Fell 17.2% in April,Motley Fool
May-10-19,Biotech Hammered On 'Shockingly Poor' Report For Breast Cancer Drug,Investor's Business Daily
May-10-19,Here's Why Puma Biotechnology Fell as Much as 40.7% Today,Motley Fool
May-10-19,Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales,TheStreet.com
May-10-19,"Puma Biotech Shares Plunge After Nerlynx Update, Quarterly Report",Benzinga
May-10-19,"Puma Biotech (PBYI) Q1 Earnings Top, Nerlynx Disappoints",Zacks
May-10-19,Puma Biotechnology Inc (PBYI) Q1 2019 Earnings Call Transcript,Motley Fool
May-10-19,Edited Transcript of PBYI earnings conference call or presentation 9-May-19 8:30pm GMT,Thomson Reuters StreetEvents
May-14-19,"Jim Cramer Gives His Opinion On Becton Dickinson, Fox, Puma Biotech And More",Benzinga
May-29-19,Puma Biotechnology to Present at Jefferies 2019 Global Healthcare Conference,Business Wire
